IGF1 and acromegaly: On the one hand, the diagnosis of acromegaly has evolved over the years from overt clinical manifestations (as viewed in subjects with advanced disease, thus exhibiting unambiguous signs and symptoms) to a milder phenotype thanks to the widespread use of MRI and ultrasensitive GH or IGF-1 assays.